Drug combination extends survival in refractory lung cancer patients, study finds
- Thu 02 Jun 2011 01:18:PM
A combination of two FDA-approved drugs extend survival in advanced-stage lung cancer patients who have run out of treatment options, according to a new study.
Source: Drug combination extends survival in refractory lung cancer patients, study finds
Source: Drug combination extends survival in refractory lung cancer patients, study finds